Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant revision.SummaryDifference1.0%
- Check93 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.